Quick Answer
Beam Therapeutics Inc. reported Stockholders Equity of $1.24 billion for fiscal year 2025.
Beam Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.24B | +68.8% |
| 2024 | $733.54M | -25.2% |
| 2023 | $981.33M | +33.8% |
| 2022 | $733.47M | -11.3% |
| 2021 | $826.74M | +236.7% |
| 2020 | $245.56M | +222.1% |
| 2019 | -$201.10M | -71.3% |
| 2018 | -$117.41M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $966.00M | +22.1% | -7.7% |
| June 30, 2025 | $1.05B | +22.6% | -6.8% |
| March 31, 2025 | $1.12B | +23.0% | +53.1% |
| December 31, 2024 | $733.54M | -25.2% | -7.3% |
| September 30, 2024 | $791.32M | +1.6% | -7.4% |
| June 30, 2024 | $854.09M | +5.2% | -6.5% |
| March 31, 2024 | $913.49M | +20.0% | -6.9% |
| December 31, 2023 | $981.33M | +33.8% | +26.0% |
- Beam Therapeutics Inc. showed an increase of +68.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Beam Therapeutics Inc.’s stockholders equity has grown by 1154.8% (from -$117.41 million to $1.24 billion).
- The most recent figure is from Beam Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: